COMP <GO>
ISRG vs JNJ // PIOTROSKI F-SCORE QUALITY
Intuitive Surgical Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ISRG 4
— JNJ 10
▲ PIOTROSKI F-SCORE QUALITY LEADER: ISRG
LAST: $432.01 (-3.73%) • MKT CAP: $155.56B
piotroski-score
9/9
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ISRG VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ISRG | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.00% | 67.90% | -1.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 15.00% | 25.50% | -10.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 46.0x | 18.5x | +27.50 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 1.66% | 2.97% | -1.31 | JNJ | /fcf-yield <GO> |
| Operating Margin | 29.30% | 34.70% | -5.40 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 28.40% | 28.50% | -0.10 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 20.50% | 6.00% | +14.50 | ISRG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.59 | +20.41 | ISRG | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 9/9 | 8/9 | +1.00 | ISRG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 7.20% | -0.40 | ISRG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 60.4 | -6.20 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 1.08 | -0.11 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 45.8x | 23.0x | +22.80 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $155.56B | $662.49B | -$506.93B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ISRG REV | JNJ REV | ISRG GROSS % | JNJ GROSS % | ISRG FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.06B | $94.19B | 66.0% | 67.9% | $2.58B | $19.70B |
| FY 2024 | $8.35B | $88.82B | 67.5% | 69.1% | $2.04B | $19.84B |
| FY 2023 | $7.12B | $85.16B | 44.0% | 44.0% | $1.49B | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ISRG // BETA 0.97
JNJ // BETA 1.08